Robert Torray
Torray Fund
Torray Fund 13F holdings
Torray Fund's Portfolio
- Portfolio value:
- $341.34M≈
- # of securities:
- 23
- Reported for:
- 28 Feb 2026 (Q1)
- Latest filing date:
- 28 Apr 2026
What is Torray Fund's portfolio?
Torray Fund has disclosed a total of 23 security holdings in their (2026 Q1) SEC filing(s) with portfolio value of $341,335,901.
Torray Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Torray Fund's original SEC reports (2026 Q1) are the official SEC institutional disclosure documents covering all reported equity positions.
23 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Phillips 66
|
6.56%
|
145,149
|
$154.33
|
+34.16%($207.05)
|
$22,400,845
|
2021 Q3
|
≈ 4.75 years
|
Common Stock
|
-9.99% (-16.1K)
|
-0.7%
|
|
|
|
Texas Instruments Incorporated
|
6.21%
|
100,000
|
$212.11
|
+32.64%($281.34)
|
$21,211,000
|
2022 Q1
|
≈ 4.25 years
|
Common Stock
|
-9.09% (-10K)
|
-0.59%
|
|
|
|
Chevron Corp
|
5.47%
|
100,000
|
$186.76
|
+4.13%($194.48)
|
$18,676,000
|
2025 Q2
|
≈ 1.00 year
|
Common Stock
|
-9.09% (-10K)
|
-0.52%
|
|
|
|
PepsiCo Inc
|
4.97%
|
100,000
|
$169.74
|
-19.58%($136.50)
|
$16,974,000
|
2025 Q3
|
≈ 0.75 years
|
Common Stock
|
|
|
|
|
|
CNA Financial Corp
|
4.92%
|
350,000
|
$48.02
|
+11.19%($53.40)
|
$16,807,000
|
2025 Q2
|
≈ 1.00 year
|
Common Stock
|
-6.67% (-25K)
|
-0.34%
|
|
|
|
Pfizer Inc
|
4.86%
|
600,000
|
$27.65
|
-11.07%($24.59)
|
$16,590,000
|
2025 Q2
|
≈ 1.00 year
|
Common Stock
|
|
|
|
|
|
ONEOK Inc
|
4.85%
|
200,000
|
$82.77
|
+13.76%($94.16)
|
$16,554,000
|
2025 Q4
|
≈ 0.50 years
|
Common Stock
|
|
|
|
|
|
Constellation Energy Corp
|
4.83%
|
50,000
|
$329.88
|
-16.39%($275.80)
|
$16,494,000
|
2026 Q1
|
≈ 0.25 years
|
Common Stock
|
new
|
+4.83%
|
|
|
|
HP ENTERPRISE CO
|
4.75%
|
275,000
|
$59.00
|
|
$16,225,000
|
2025 Q2
|
≈ 1.00 year
|
Preferred Stock
|
|
|
|
|
|
Royalty PharmaPlc
|
4.74%
|
350,000
|
$46.21
|
+26.79%($58.59)
|
$16,173,500
|
2023 Q2
|
≈ 3.00 years
|
Common Stock
|
-11.90% (-47.29K)
|
-0.61%
|
|
Completely sold out
3 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
American Express Company
|
-55,285
|
-5.65%
|
2020 Q1
|
≈ 6.00 years
|
|
|
|
UnitedHealth Group Incorporated
|
-45,000
|
-4.15%
|
2020 Q1
|
≈ 6.00 years
|
|
|
|
Lennar Corp
|
-110,000
|
-3.8%
|
2022 Q4
|
≈ 3.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.